Smruthi Organics Ltd — Important, 04-03-2026: Company Update

Smruthi Organics has secured an Attestation of Inspection from the European Directorate for the Quality of Medicines & HealthCare (EDQM). This significant achievement confirms that the company's key API manufacturing facility in Solapur meets stringent European Good Manufacturing Practice (EU GMP) standards for Amlodipine Besilate. This clearance is crucial for Smruthi Organics, as it ensures continued market access and strengthens its position to supply this important active pharmaceutical ingredient within the highly regulated European market, validating the quality and operational excellence of its production capabilities.